[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.161.178.52. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Views 484
Citations 0
Editorial
September 2016

The Puzzle of Huntington Disease Phenocopies

Author Affiliations
  • 1Faculty of Medicine, Laval University, Quebec City, Quebec, Canada
  • 2Clinic of Neuromuscular and Neurogenetic Diseases, Centre Hospitalier Universitaire de Québec-Université Laval, Quebec City, Quebec, Canada
  • 3Department of Neurology and Neurosurgery, Montreal Neurological Institute, McGill University, Montreal, Quebec, Canada
JAMA Neurol. 2016;73(9):1056-1058. doi:10.1001/jamaneurol.2016.2095

Huntington disease (HD) is a progressive disorder causing motor, cognitive, and psychiatric disturbances, with a mean age at onset of 35 to 44 years and a median survival time of 15 to 18 years.1 Although most cases have the classic triplet repeat expansion, HD specialists all follow up patients who have all the cardinal features of HD but do not have the HD mutation. These cases are problematic because genetic counseling is difficult, the prognosis is uncertain, and the fear is that a potentially treatable condition may be missed.

First Page Preview View Large
First page PDF preview
First page PDF preview
×